Tamtam Try Tamtam free
The Ohio State University Wexner Medical Center logo

The Ohio State University Wexner Medical Center account plan

Comprehensive Academic Medical Center

At a glance

Ohio State Wexner Medical Center is central Ohio's academic medical center: seven hospitals, nearly 1,500 beds, $6.28 billion Health System revenue in FY2026.

The Ohio State University Wexner Medical Center is the academic medical center of The Ohio State University, a public university and component unit of the State of Ohio; its Ohio State Health System is governed by the university's Board of Trustees. The Health System runs seven hospitals, a network of ambulatory care locations and nearly 1,500 open inpatient beds, providing primary to quaternary care and serving as a tertiary and quaternary referral center for Ohio and the Midwest. In FY2025 (year to June 30, 2025) it treated about 61,200 inpatients and 1,803,000 outpatients. In FY2026 (year to June 30, 2026, unaudited) Health System sales and services rose 13.9% to $6.28 billion and the physician group Ohio State University Physicians, Inc. (OSUP) rose 8.0% to $1.30 billion, together $7,585 million, about 70% of university operating revenue (computed).

Business units

Strategic priorities

Ramping up the new University Hospital
The 26-story tower opened in February 2026; the FY2027 plan expects inpatient discharges to grow 7.0% with its added bed capacity, and the Health System is focused on throughput, workforce retention and optimizing the new hospital.
Outpatient and specialty growth
The FY2027 plan targets outpatient activity +5.1% (imaging, rehab, surgery, drug infusions) and surgery +3.9%, with the cancer program, new ambulatory services and surgical specialties leading growth; Health System sales and services are planned at $6.66 billion, up 7.1%.
Workforce retention and recruitment
The FY2027 plan adds about 1,300 FTEs with 3.0% merit plus 1.5% market salary increases; FY2026 had planned 5.5% increases for the Health System and OSUP.
Margin discipline
The Health System budgets a $213.8 million margin for FY2027 (3.2% total margin, 8.9% EBIDA margin), relying on revenue enhancement and performance improvement initiatives to offset inflation in labor, supplies, drugs and services.
Cancer care access across Ohio
The James CEO is prioritising awareness of early-onset cancer and research-based care in underserved rural, Appalachian and urban areas, adding the community as a fourth leg of the mission.
Education for Citizenship 2035
The university's 10-year plan funds the hospital tower, research expansion toward $2 billion, 100 new AI faculty and tuition-free pathways.

Latest results

In FY2026 (year to June 30, 2026, unaudited), Ohio State Health System sales and services rose $767 million (13.9%) to $6,280.7 million and OSU Physicians rose $96 million (8.0%) to $1,303.9 million. Growth came from higher inpatient acuity, outpatient services, and infusion, radiation, imaging, cardiac and transplant volumes that beat both budget and prior year, plus the new University Hospital and specialty pharmacy. Health System expenses rose 9.5% to $5,441.3 million. The university's operating loss narrowed to $567.1 million from $690.0 million, and total debt fell to $4,250 million after a $561 million refunding. For FY2027 the plan sets Health System sales and services at $6.66 billion (+7.1%) and a $213.8 million margin.

Investments and deals

New University Hospital
A $1.79 billion, 26-story, 1.9 million square foot tower with 820 private rooms and 234 intensive care beds, the largest facilities project in the university's history; opened in February 2026, with $46.9 million remaining in the capital plan.
Suburban outpatient program
Outpatient Care Powell ($183 million, opening August 2026) follows New Albany and Dublin; the capital plan also lists Outpatient Care West Campus ($10.4 million).
Interim Capital Investment Plan through FY2031
$1.37 billion across the university and the Wexner Medical Center ($754.0 million prior commitments, $613.4 million new), including a magnetic resonance linear accelerator ($10.3 million), an OSU East OR renovation ($7.5 million), the James Cellular Therapy Lab ($6.8 million) and the Doan Hall roof ($14.0 million); a $400 million bond issuance is assumed in FY2027.
Health System capital additions
The Health System accounted for $647 million of the university's $1.06 billion of capital additions in FY2025, covering facilities, infrastructure, land and equipment.

Challenges and risks

Rising labor, supply and drug costs
FY2025 Health System operating expenses rose $577.1 million (12.8%), including supplies and drugs +$299.6 million (19.9%) and purchased services +$119.6 million (18.6%); the FY2027 plan expects operating expenses +9.6% and drugs +7.8%.
Reimbursement pressure
The FY2027 plan assumes government base rates of only +1.0%, reductions from the 340B program and HCAP state directed payments, and healthcare reform impacts on reimbursement.
Thin budgeted margin
The FY2027 budgeted total margin is 3.2%, down from a FY2026 forecast of $367.6 million to $213.8 million, while it must fund $595.0 million of faculty support.
Heavy capital needs
Net capital uses of $341.3 million in FY2027 reduce the Health System's $446.9 million operating surplus to $105.6 million after capital.
Receivables and legal costs
Health System patient care receivables rose $173 million in FY2026, and the university booked an $80 million accrual for legal settlements.

What leadership says

“This needs to be done in an ecosystem or laboratory, and our laboratory is Ohio”

W. Kimryn Rathmell, CEO of OSUCCC - James · Company-site interview on her vision for The James, May 27, 2025

“It's a substantial enough gift that it can become pilot or seed money for projects that take us in new and exciting directions.”

W. Kimryn Rathmell, CEO of OSUCCC - James · On the $10 million Block and Schottenstein endowed chair, company-site interview, May 27, 2025

“Ultimately, it will be a world where people don't fear cancer the way we do today.”

W. Kimryn Rathmell, CEO of OSUCCC - James · On a cancer-free world, company-site interview, May 27, 2025

Where a supplier can help

Operating the new hospital tower
With the tower open since February 2026 and throughput and optimization of the new hospital a stated priority, suppliers of patient-flow, bed management, facilities and clinical equipment services have a live need.
Workforce retention
About 1,300 planned FTE additions and retention as a stated focus open doors for recruiting, staffing, scheduling and employee-experience offers.
Drug and supply cost control
Supplies and drugs rose 19.9% in FY2025 and drugs are budgeted +7.8% in FY2027, so procurement, pharmacy and infusion cost-management solutions tie directly to the margin target.
Outpatient and suburban expansion
Outpatient Care Powell opening and the outpatient growth target create demand for ambulatory equipment, imaging, IT and building services.
Cancer outreach and research
The James CEO's focus on early-onset cancer and community outreach across rural and urban Ohio, plus seed money from the endowed chair, suits screening, outreach and clinical-trial partners.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like The Ohio State University Wexner Medical Center?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about The Ohio State University Wexner Medical Center

What is The Ohio State University Wexner Medical Center?

It is the academic medical center of The Ohio State University. Its Ohio State Health System runs seven hospitals, including University Hospital and The James cancer hospital, plus ambulatory care locations, with nearly 1,500 open inpatient beds.

What is the Wexner Medical Center's revenue?

In FY2026 (year to June 30, 2026, unaudited) Ohio State Health System sales and services were $6.28 billion, up 13.9%, and OSU Physicians $1.30 billion; together $7,585 million.

What is the new University Hospital?

A $1.79 billion, 26-story tower with 820 private rooms and 234 intensive care beds that opened in February 2026 and is expected to drive 7.0% inpatient discharge growth in FY2027.

What are its priorities for FY2027?

Growing Health System sales and services 7.1% to $6.66 billion, ramping up the new hospital, outpatient and cancer program growth, adding about 1,300 FTEs, and holding a 3.2% total margin.

Who leads The James cancer hospital?

W. Kimryn Rathmell, MD, PhD, former director of the National Cancer Institute, is CEO of OSUCCC - James.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)